Clinical Trial Update: Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of TUTI-16 in asymptomatic HIV-1 infected subjects has completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TUTI-16

Snippet

Sponsor: Thymon, LLC | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-02-15